Study into the effects of ischaemic pre-conditioning (IPC) on ischaemia-reperfusion injury (IRI) in patients with peripheral vascular disease

ISRCTN ISRCTN18883083
DOI https://doi.org/10.1186/ISRCTN18883083
Secondary identifying numbers N0436130382
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
13/09/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof S Homer-Vanniasinkam
Scientific

Vascular Surgical Unit
Clarendon Wing
Leeds Teaching Hospitals NHS Trust
Great George Street
Leeds
LS1 3EX
United Kingdom

Phone +44 (0)113 392 2947
Email shervanthi.homer-vanniasinkam@leedsth.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleStudy into the effects of ischaemic pre-conditioning (IPC) on ischaemia-reperfusion injury (IRI) in patients with peripheral vascular disease
Study objectivesThe aim of this study is to show that both local and remote pre-conditioning is protective against reperfusion injury in high risk subjects.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCardiovascular: Peripheral vascular disease
InterventionLaboratory study; Randomised controlled trial; Qualitative methodology.
Exercise on treadmill until symptoms of reperfusion injury are reproduced. This is preceeded by preconditioning exercises (warm up exercises) in some cases vs no preconditioning exercises in other cases.
Intervention typeOther
Primary outcome measureReduction in complications of reperfusion injury as measured by
1. Metabolites
1.1. Lactate
1.2. Blood pH
1.3. Interleukin 6 (IL-6)
1.4. Heat shock protein (HSP)
1.5. Nitric oxide (NO)
2. Blood constituents
2.1. Activated platelets
2.2. Platelet-leucocyte aggregates
Secondary outcome measuresNot provided at time of registration
Overall study start date01/04/2003
Completion date01/04/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteriaStudy group - volunteers selected from patients with peripheral vascular disease (outpatients) who experience symptoms of claudication; control subjects will be age-matched volunteers.
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/04/2003
Date of final enrolment01/04/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Vascular Surgical Unit
Leeds
LS1 3EX
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Leeds Teaching Hospitals NHS Trust UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

13/09/2016: No publications found in PubMed, verifying study status with principal investigator.